Washington State investigators found serious violations at a Mochi Health-affiliated compounding pharmacy producing GLP-1s, and a med spa bill in Indiana hears public testimony about a med spa bill.
A startup pharmacy in Washington, owned by Mochi Health, is under investigation after whistleblowers alleged it allowed unlicensed workers to handle and package compounded GLP-1 weight-loss drugs in violation of state law. Former employees told KING 5 that workers recruited from hardware store parking lots were allowed into restricted areas, where they accessed refrigerators stocked with patient-labeled medications and packaged prescriptions. Investigators allege that the laborers were sorting and labeling drugs while managers looked on. Pharmacists, whose salaries were based on output, said they were pressured to verify prescriptions in seconds to maximize output.
The Washington State Department of Health found multiple violations and temporarily restricted Aequita’s compounding license, though the agency says the company has since addressed deficiencies and remains under investigation. Whistleblowers also described cost-cutting measures dubbed “Glassgate,” which involved the use of cheap vials from Alibaba and frozen Otter Pops instead of medical-grade ice packs, alongside reports of contaminated medication vials. Some customers reported serious illness after injections, and authorities in multiple states are investigating related complaints.
Home Politics Top News Minister of Foreign Affairs Lin Chia-lung firmly refuted a statement in which Wang Yi, China’s foreign minister, said Taiwan was part of China. Lin said March 8 that th...